[Recurrent hyperkalaemia management and use of renin-angiotensin-aldosterone system inhibitors: Analysis of French data from the PROKALE multinational European study].
Fiche publication
Date publication
mai 2021
Journal
Nephrologie & therapeutique
Auteurs
Membres identifiés du Cancéropôle Est :
Pr ROSSIGNOL Patrick
Tous les auteurs :
Rossignol P,
Lien Pubmed
Résumé
Recurrent hyperkalaemia may result in underutilisation of renin-angiotensin-aldosterone system inhibitors. We report an analysis of French data from the PROKALE retrospective study, which assessed the management of recurrent hyperkalaemia in five European countries.
Mots clés
Cardiorenal syndrome, Chronic kidney disease, Heart failure, Hyperkalaemia, Hyperkaliémie, Inhibiteur du système Rénine-angiotensine-aldostérone, Insuffisance cardiaque, Insuffisance rénale chronique, Prognosis, Pronostic, Renin-angiotensin-aldosterone system inhibitors, Syndrome cardio-rénal
Référence
Nephrol Ther. 2021 May 11;: